New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Police raid suspected marijuana shop above Georgetown book storeon December 5, 2019 at 5:17 pm
On Tuesday, D.C. police raided the stucco house on 33rd Street, just off Wisconsin Avenue, alleging the renters sold marijuana. Police said they also sold products infused with cannabidiol, or CBD, ...
- Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Researchon December 5, 2019 at 4:03 pm
TEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects ...
- Tauriga Sciences, Inc. to Develop a Cannabigerol CBG Infused Product to Complement its Existing CBD Infused Edibles Product Line(s)on December 5, 2019 at 4:01 pm
One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in ...
- Ankeny store owner arrested for selling CBD products while unlicensedon December 5, 2019 at 9:14 am
The owner of Your CBD Store is charged with two counts of controlled substance violation and unlawful substance tax requirement.
- Some owners swear by CBD's effects on pets, but veterinary board has no guidelines yeton December 5, 2019 at 8:28 am
Both of their owners, Sean Partridge and David Reich respectively, give them cannabidiol or CBD, a cannabis ingredient derived from hemp plants, and say the substance has improved the quality of their ...
- How To Start A Successful CBD Business In 2020on December 5, 2019 at 8:03 am
By focusing on Cannabidiol (CBD) products, for instance, any good cannabis entrepreneur stands to make a killing before long. You’ll need to do your homework before investing your money if you really ...
- 10 Hot Pot Stocks to Buyon December 5, 2019 at 5:32 am
Unfortunately, we can’t quite say the same about pot stocks to buy. Call it a case of misplaced expectations. While the federal government green-lighting industrial hemp opened the doorway to products ...
- Meeting Highlights Include New Phase 3 Data for EPIDIOLEX in Tuberous Sclerosis Complex and Award-Winning Virtual Reality Experienceon December 5, 2019 at 4:24 am
Dec. 05, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, along with U.S.
- CBD-Based Skincare and Wellness Products For Cannabidiol Newbieson December 4, 2019 at 8:46 am
Others attest that tea tree oil is the cure-all for skin woes. Then there’s Argan, Marula and most recently, Pili oils. One particular natural ingredient that’s piqued interest is cannabidiol or CBD ...
- Willow Biosciences Comments on Descheduling of Partner's Cannabidiol by U.S. Drug Enforcement Agencyon December 3, 2019 at 3:30 am
CALGARY, Dec. 3, 2019 /PRNewswire/ - Willow Biosciences Inc. ("Willow" or the "Company") (WLLW)(otcqb:CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced ...
via Bing News